The emperor redressed: treating osteoporosis to prevent hip fractures in the oldest old

Managing osteoporosis and preventing hip fractures in the oldest old remains a challenge surrounded by controversy and strong opinions. This is understandable given the paucity of randomized controlled trial (RCT) data in patients aged 80 years and above [1], the legitimate concerns that efficacy would disappoint given the multiple comedications and comorbid conditions that are prevalent in many of the oldest osteoporosis patients, and the probability that adverse effects would be more common and more severe in this age group. This article is protected by copyright. All rights reserved.